Non-structural protein 6 (NSP6)

Rotavirus non-structural protein 6 (NSP6) is a small viral protein, typically around 12 kDa, encoded by an out-of-phase open reading frame within genome segment 11 of Rotavirus A [PMID: 10482570]. It is expressed in most but not all rotavirus strains and is characterized by a very high turnover rate, with a half-life of less than two hours in infected cells [PMID: 10742137]. The protein primarily localizes to viroplasms, the cytoplasmic sites of viral replication and assembly, where it is known to interact with the non-structural protein NSP5 [PMID: 11435579]. NSP6 functions as a sequence-independent nucleic acid binding protein, exhibiting comparable affinity for both single-stranded and double-stranded RNA [PMID: 10742137]. In addition to its role in viral factories, NSP6 has been observed to target host mitochondria via a conserved N-terminal alpha-helix, suggesting a role in subverting host cellular processes during infection [PMID: 26354483]. Studies using reverse genetics systems have indicated that while the protein is conserved, it is not strictly essential for viral replication in certain cell culture environments [PMID: 28794037]. Due to its specific presence in viral infections and lack of human homologs, NSP6 represents a potential target for the development of novel anti-rotaviral therapeutics. Currently, there are no approved drugs or clinical candidates that specifically target NSP6, and its precise biological function remains a subject of active scientific investigation [PMID: 22694356].

Other names

NSP6Non-structural protein 6NS26Protein NSP6

No drugs currently target this protein; however, hypothetical therapeutic approaches would involve the disruption of viroplasm formation or interference with viral RNA binding.